John Gordon Freund's Net Worth

$329 Million

Who is John Gordon Freund?

John Gordon Freund has an estimated net worth of $329 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, MAKO Surgical Corp., MAP Pharmaceuticals, Inc., TETRAPHASE PHARMACEUTICALS INC, Targanta Therapeutics Corp., Sirtris Pharmaceuticals, Inc., SI-BONE, Inc., COLLEGIUM PHARMACEUTICAL, INC, SUTRO BIOPHARMA, INC., CONCERT PHARMACEUTICALS, INC., PROTEON THERAPEUTICS INC, ACELRX PHARMACEUTICALS INC, XENOPORT INC, and HANSEN MEDICAL INC.

SEC CIK

John Gordon Freund's CIK is 0001296771

Past Insider Trading and Trends

2014 was John Gordon Freund's most active year for acquiring shares with 25 total transactions. John Gordon Freund's most active month to acquire stocks was the month of April. 2014 was John Gordon Freund's most active year for disposing of shares, totalling 44 transactions. John Gordon Freund's most active month to dispose stocks was the month of September. 2007 saw John Gordon Freund paying a total of $52,269,192.13 for 5,478,526 shares, this is the most they've acquired in one year. In 2013 John Gordon Freund cashed out on 46,410,704 shares for a total of $83,441,831.24, their largest year based on trade value.